Ingela Nilsson

466 total citations
19 papers, 367 citations indexed

About

Ingela Nilsson is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Ingela Nilsson has authored 19 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Ingela Nilsson's work include Liver physiology and pathology (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Diet and metabolism studies (3 papers). Ingela Nilsson is often cited by papers focused on Liver physiology and pathology (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Diet and metabolism studies (3 papers). Ingela Nilsson collaborates with scholars based in Sweden, Australia and Chile. Ingela Nilsson's co-authors include Lars Brudin, Fariba Nayeri, Martin Carlsson, T. Teerlink, Lars Brattström, Py Palmqvist, Pia Forsberg, Gunnar Johansson, Linda Hagfors and Lars Sköldstam and has published in prestigious journals such as The Lancet, Journal of Bacteriology and Journal of Medicinal Chemistry.

In The Last Decade

Ingela Nilsson

19 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingela Nilsson Sweden 11 86 82 61 58 58 19 367
Dong-Yeop Chang South Korea 10 59 0.7× 98 1.2× 58 1.0× 32 0.6× 69 1.2× 10 437
Virgínia Hora Rios Leite Brazil 11 47 0.5× 142 1.7× 70 1.1× 108 1.9× 72 1.2× 25 405
Julia D. Rempel Canada 16 80 0.9× 201 2.5× 25 0.4× 54 0.9× 88 1.5× 36 659
Yoshio Kitamura Japan 7 68 0.8× 38 0.5× 103 1.7× 67 1.2× 50 0.9× 17 409
B. C. Tennant United States 14 73 0.8× 165 2.0× 19 0.3× 85 1.5× 48 0.8× 19 489
Ya Huang China 14 49 0.6× 239 2.9× 94 1.5× 85 1.5× 109 1.9× 26 599
Francesca Graziano Italy 14 52 0.6× 162 2.0× 24 0.4× 63 1.1× 114 2.0× 25 551
Sarah Sugden United Kingdom 9 45 0.5× 71 0.9× 30 0.5× 101 1.7× 200 3.4× 10 683
Minoru Kino Japan 13 39 0.5× 75 0.9× 55 0.9× 131 2.3× 124 2.1× 33 440
Tatsuya Ando Japan 18 43 0.5× 123 1.5× 31 0.5× 204 3.5× 151 2.6× 57 791

Countries citing papers authored by Ingela Nilsson

Since Specialization
Citations

This map shows the geographic impact of Ingela Nilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingela Nilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingela Nilsson more than expected).

Fields of papers citing papers by Ingela Nilsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingela Nilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingela Nilsson. The network helps show where Ingela Nilsson may publish in the future.

Co-authorship network of co-authors of Ingela Nilsson

This figure shows the co-authorship network connecting the top 25 collaborators of Ingela Nilsson. A scholar is included among the top collaborators of Ingela Nilsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingela Nilsson. Ingela Nilsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Pettersson, John H.‐O., Patrik Ellström, Jiaxin Ling, et al.. (2020). Circumpolar diversification of the Ixodes uriae tick virome. PLoS Pathogens. 16(8). e1008759–e1008759. 25 indexed citations
2.
Good, James A. D., et al.. (2017). Thiazolino 2-Pyridone Amide Isosteres As Inhibitors of Chlamydia trachomatis Infectivity. Journal of Medicinal Chemistry. 60(22). 9393–9399. 23 indexed citations
3.
Carlsson, Martin, et al.. (2016). Erythrocyte fatty acid composition does not influence levels of free, bioavailable, and total 25-hydroxy vitamin D. Scandinavian Journal of Clinical and Laboratory Investigation. 77(1). 45–52. 3 indexed citations
4.
Brudin, Lars, et al.. (2014). Hepatocyte Growth Factor Is a Reliable Marker for Efficient Anti-Bacterial Therapy within the First Day of Treatment. Advances in Bioscience and Biotechnology. 5(10). 823–830. 3 indexed citations
5.
Engström, Patrik, Bidong D. Nguyen, Johan Normark, et al.. (2013). Mutations in hemG Mediate Resistance to Salicylidene Acylhydrazides, Demonstrating a Novel Link between Protoporphyrinogen Oxidase (HemG) and Chlamydia trachomatis Infectivity. Journal of Bacteriology. 195(18). 4221–4230. 29 indexed citations
6.
Carlsson, Martin, Ingela Nilsson, Torbjörn Lindström, et al.. (2010). Weight gain by hyperalimentation elevates C-reactive protein levels but does not affect circulating levels of adiponectin or resistin in healthy subjects. European Journal of Endocrinology. 163(6). 879–885. 17 indexed citations
7.
Öhman, Marie, Torbjörn Åkerfeldt, Ingela Nilsson, et al.. (2008). Biochemical effects of consumption of eggs containing omega-3 polyunsaturated fatty acids. Upsala Journal of Medical Sciences. 113(3). 315–324. 10 indexed citations
8.
9.
Teerlink, T., Lars Brudin, Lars Brattström, et al.. (2005). Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population. Atherosclerosis. 185(2). 271–277. 91 indexed citations
10.
Hagfors, Linda, Ingela Nilsson, Lars Sköldstam, & Gunnar Johansson. (2005). Fat intake and composition of fatty acids in serum phospholipids in a randomized, controlled, Mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutrition & Metabolism. 2(1). 26–26. 36 indexed citations
11.
Nayeri, Fariba, Ingela Nilsson, Lars Brudin, & Sven Almér. (2004). Stability of faecal hepatocyte growth factor determination. Scandinavian Journal of Clinical and Laboratory Investigation. 64(6). 589–598. 4 indexed citations
12.
Nayeri, Fariba, Sven Almér, Lars Brudin, et al.. (2003). High Hepatocyte Growth Factor Levels in Faeces During Acute Infectious Gastroenteritis. Scandinavian Journal of Infectious Diseases. 35(11-12). 858–862. 6 indexed citations
13.
Nayeri, Fariba, et al.. (2002). High Serum Hepatocyte Growth Factor Levels in the Acute Stage of Community-acquired Infectious Diseases. Scandinavian Journal of Infectious Diseases. 34(2). 127–130. 19 indexed citations
14.
Nayeri, Fariba, Lars Brudin, Ingela Nilsson, & Pia Forsberg. (2002). SAMPLE HANDLING AND STABILITY OF HEPATOCYTE GROWTH FACTOR IN BLOOD SAMPLES. Cytokine. 19(4). 201–205. 18 indexed citations
15.
Nayeri, Fariba, et al.. (2002). Exhaled breath condensate and serum levels of hepatocyte growth factor in pneumonia. Respiratory Medicine. 96(2). 115–119. 21 indexed citations
16.
Nayeri, Fariba, et al.. (2002). Hepatocyte Growth Factor may Act as an Early Therapeutic Predictor in Pneumonia. Scandinavian Journal of Infectious Diseases. 34(7). 500–504. 10 indexed citations
17.
Nayeri, Fariba, et al.. (2000). Hepatocyte Growth Factor Levels in Cerebrospinal Fluid: A Comparison between Acute Bacterial and Nonbacterial Meningitis. The Journal of Infectious Diseases. 181(6). 2092–2094. 26 indexed citations
18.
Druid, Henrik, Ingela Nilsson, Lennart Rammer, & G. Skude. (1999). Effect of Anticoagulation on Renal Function and Protein Excretion in Experimental Acute Ischemic Renal Failure. Renal Failure. 21(6). 647–657. 2 indexed citations
19.
Nilsson, Ingela, et al.. (1975). FACTOR VIII AND GLOMERULONEPHRITIS. The Lancet. 305(7916). 1111–1113. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026